Abridge, an AI startup automating medical notes, has secured a $300 million Collection E at a $5.3 billion valuation, in response to the Wall Avenue Journal. The spherical, led by Andreessen Horowitz with participation from Khosla Ventures, follows the corporate’s $250 million February fundraise at a $2.75 billion valuation.
The 7-year-old Abridge is broadly thought-about to be the chief within the more and more crowded AI-powered medical scribe market, largely on account of its early entry and integration with Epic Methods, the dominant well being report software program.
In Q1, Abridge reached $117 million in contracted annual recurring income (a metric that features all signed recurring contacts, together with from prospects which have nonetheless not been onboarded), The Info reported final month.
Together with the fundraise, Abridge introduced that it’s increasing into changing medical notes from affected person appointments into AI-powered medical codes, an providing that makes the corporate straight aggressive with startups like CodaMetrix and a function from its companion Epic Methods.
Abridge, which was based by heart specialist Shiv Rao, claims that its AI scribe know-how is utilized by over 150 of the most important well being methods within the U.S.
